![Transparency Market Researchが調査・発行した産業分析レポートです。世界の迅速医療診断キット市場2021年ｰ2028年：用途別（臨床検査用[感染症検査、コレステロールモニタリング、物質乱用検査、不妊・妊娠検査、血糖検査]、家庭用[感染症検査、コレステロールモニタリング、物質乱用検査、不妊・妊娠検査]、動物用）、技術別 / Rapid Medical Diagnostic Kits Market (Application: Clinical Testing [Infectious Disease Testing, Cholesterol Monitoring, Substance Abuse Testing, Fertility & Pregnancy Testing, and Blood Glucose Testing], Home Use [Infectious Disease Testing, Cholesterol Monitoring, Substance Abuse Testing, Fertility & Pregnancy Testing, and Blood Glucose Testing], and Veterinary; and Technology: Lateral Flow, Flow-through, Solid-phase, and Agglutination Assays) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 / MRC2205A024資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/report-contents-24.gif) | • レポートコード：MRC2205A024 • 出版社/出版日：Transparency Market Research / 2022年3月22日 • レポート形態：英文、PDF、356ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、世界の迅速医療診断キット市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、用途別（臨床検査用、家庭用、動物用）分析、技術別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の迅速医療診断キット市場規模：用途別（臨床検査用、家庭用、動物用） ・世界の迅速医療診断キット市場規模：技術別 ・世界の迅速医療診断キット市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Rapid Medical Diagnostic Kits Market – Scope of Report
TMR’s report on the rapid medical diagnostic kits market studies the past as well as current growth trends and opportunities to gain valuable insights into the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global rapid medical diagnostic kits market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global rapid medical diagnostic kits market during the forecast period.
The report has been prepared after extensive primary and secondary research. Primary research involved a bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion-makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global rapid medical diagnostic kits.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study the various phenomenon in the global rapid medical diagnostic kits.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global rapid medical diagnostic kits. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global rapid medical diagnostic kits.
The market overview section of the report demonstrates the qualitative analysis of the market dynamics of the global rapid medical diagnostic kits market and includes information about the drivers, restraints, opportunities, Porter’s Five Forces analysis, and market attractiveness analysis of the market.
The report delves into the competitive landscape of the global rapid medical diagnostic kits. Key players operating in the global rapid medical diagnostic kits market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the rapid medical diagnostic kits market that have been profiled in this report.
The company profiles section of the report includes information about the major market players. Leading players in the market include Abbott Laboratories, Abaxis, Inc., Alere, Inc., Becton, Dickinson & Company, BioRad Laboratories, F. Hoffmann La Roche, MegaCor, Trinity Biotech, and Zoetis, Inc.
Key Questions Answered in Rapid Medical Diagnostic Kits Market Report
What is the scope of growth of product companies in the global rapid medical diagnostic kits?
What will be the Y-o-Y growth of the global rapid medical diagnostic kits market between 2017 and 2028?
What is the influence of changing trends in technologies on the global rapid medical diagnostic kits?
Will North America be the most profitable market for rapid medical diagnostic kits providers?
Which factors are anticipated to hamper the growth of the global rapid medical diagnostic kits market during the forecast period?
Which are the leading companies in the global rapid medical diagnostic kits?
Research Methodology
TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global rapid medical diagnostic kits market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the rapid medical diagnostic kits market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the global rapid medical diagnostic kits market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the rapid medical diagnostic kits market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the rapid medical diagnostic kits market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the rapid medical diagnostic kits market more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Rapid Medical Diagnostic Kits Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Rapid Medical Diagnostic Kits Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Pipeline Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic’s Impact on Industry (value chain and short / mid / long term impact)
6. Global Rapid Medical Diagnostic Kits Market Analysis and Forecast, By Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Application, 2017–2028
6.3.1. Clinical Testing
6.3.1.1. Infectious Disease Testing
6.3.1.2. Cholesterol Monitoring
6.3.1.3. Substance Abuse Testing
6.3.1.4. Fertility & Pregnancy Testing
6.3.1.5. Blood Glucose Testing
6.3.2. Home Use
6.3.2.1. Infectious Disease Testing
6.3.2.2. Cholesterol Monitoring
6.3.2.3. Substance Abuse Testing
6.3.2.4. Fertility & Pregnancy Testing
6.3.2.5. Blood Glucose Testing
6.3.3. Veterinary
6.4. Market Attractiveness By Application
7. Global Rapid Medical Diagnostic Kits Market Analysis and Forecast, By Technology
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Technology, 2017–2028
7.3.1. Lateral Flow
7.3.2. Flow-through
7.3.3. Solid-phase
7.3.4. Agglutination Assays
7.4. Market Attractiveness Analysis, By Technology
8. Global Rapid Medical Diagnostic Kits Market Analysis and Forecast, By Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, By Region
9. North America Rapid Medical Diagnostic Kits Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Application, 2017–2028
9.2.1. Clinical Testing
9.2.1.1. Infectious Disease Testing
9.2.1.2. Cholesterol Monitoring
9.2.1.3. Substance Abuse Testing
9.2.1.4. Fertility & Pregnancy Testing
9.2.1.5. Blood Glucose Testing
9.2.2. Home Use
9.2.2.1. Infectious Disease Testing
9.2.2.2. Cholesterol Monitoring
9.2.2.3. Substance Abuse Testing
9.2.2.4. Fertility & Pregnancy Testing
9.2.2.5. Blood Glucose Testing
9.2.3. Veterinary
9.3. Market Value Forecast, by Technology, 2017–2028
9.3.1. Lateral Flow
9.3.2. Flow-through
9.3.3. Solid-phase
9.3.4. Agglutination Assays
9.4. Market Value Forecast, by Country, 2017–2028
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By Technology
9.5.3. By Country
10. Europe Rapid Medical Diagnostic Kits Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Application, 2017–2028
10.2.1. Clinical Testing
10.2.1.1. Infectious Disease Testing
10.2.1.2. Cholesterol Monitoring
10.2.1.3. Substance Abuse Testing
10.2.1.4. Fertility & Pregnancy Testing
10.2.1.5. Blood Glucose Testing
10.2.2. Home Use
10.2.2.1. Infectious Disease Testing
10.2.2.2. Cholesterol Monitoring
10.2.2.3. Substance Abuse Testing
10.2.2.4. Fertility & Pregnancy Testing
10.2.2.5. Blood Glucose Testing
10.2.3. Veterinary
10.3. Market Value Forecast, by Technology, 2017–2028
10.3.1. Lateral Flow
10.3.2. Flow-through
10.3.3. Solid-phase
10.3.4. Agglutination Assays
10.4. Market Value Forecast, by Country/Sub-Region, 2017–2028
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By Technology
10.5.3. By Country/Sub-Region
11. Asia Pacific Rapid Medical Diagnostic Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Application, 2017–2028
11.2.1. Clinical Testing
11.2.1.1. Infectious Disease Testing
11.2.1.2. Cholesterol Monitoring
11.2.1.3. Substance Abuse Testing
11.2.1.4. Fertility & Pregnancy Testing
11.2.1.5. Blood Glucose Testing
11.2.2. Home Use
11.2.2.1. Infectious Disease Testing
11.2.2.2. Cholesterol Monitoring
11.2.2.3. Substance Abuse Testing
11.2.2.4. Fertility & Pregnancy Testing
11.2.2.5. Blood Glucose Testing
11.2.3. Veterinary
11.3. Market Value Forecast, by Technology, 2017–2028
11.3.1. Lateral Flow
11.3.2. Flow-through
11.3.3. Solid-phase
11.3.4. Agglutination Assays
11.4. Market Value Forecast, by Country/Sub-Region, 2017–2028
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By Technology
11.5.3. By Country/Sub-Region
12. Latin America Rapid Medical Diagnostic Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Application, 2017–2028
12.2.1. Clinical Testing
12.2.1.1. Infectious Disease Testing
12.2.1.2. Cholesterol Monitoring
12.2.1.3. Substance Abuse Testing
12.2.1.4. Fertility & Pregnancy Testing
12.2.1.5. Blood Glucose Testing
12.2.2. Home Use
12.2.2.1. Infectious Disease Testing
12.2.2.2. Cholesterol Monitoring
12.2.2.3. Substance Abuse Testing
12.2.2.4. Fertility & Pregnancy Testing
12.2.2.5. Blood Glucose Testing
12.2.3. Veterinary
12.3. Market Value Forecast, by Technology, 2017–2028
12.3.1. Lateral Flow
12.3.2. Flow-through
12.3.3. Solid-phase
12.3.4. Agglutination Assays
12.4. Market Value Forecast, by Country/Sub-Region, 2017–2028
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By Technology
12.5.3. By Country/Sub-Region
13. Middle East & Africa Rapid Medical Diagnostic Kits Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Application, 2017–2028
13.2.1. Clinical Testing
13.2.1.1. Infectious Disease Testing
13.2.1.2. Cholesterol Monitoring
13.2.1.3. Substance Abuse Testing
13.2.1.4. Fertility & Pregnancy Testing
13.2.1.5. Blood Glucose Testing
13.2.2. Home Use
13.2.2.1. Infectious Disease Testing
13.2.2.2. Cholesterol Monitoring
13.2.2.3. Substance Abuse Testing
13.2.2.4. Fertility & Pregnancy Testing
13.2.2.5. Blood Glucose Testing
13.2.3. Veterinary
13.3. Market Value Forecast, by Technology, 2017–2028
13.3.1. Lateral Flow
13.3.2. Flow-through
13.3.3. Solid-phase
13.3.4. Agglutination Assays
13.4. Market Value Forecast, by Country/Sub-Region, 2017–2028
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By Technology
13.5.3. By Country/Sub-Region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Company Profiles
14.2.1. Abbott Laboratories
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. Abaxis, Inc.
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.2.2. Product Portfolio
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. Alere, Inc.
14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2. Product Portfolio
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. Becton Dickinson & Company
14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.4.2. Product Portfolio
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. BioRad Laboratories
14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.5.2. Product Portfolio
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. F. Hoffmann La Roche
14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.6.2. Product Portfolio
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. MegaCor
14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.7.2. Product Portfolio
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. Trinity Biotech
14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.8.2. Product Portfolio
14.2.8.3. Financial Overview
14.2.8.4. Strategic Overview
14.2.8.5. SWOT Analysis
14.2.9. Zoetis, Inc.
14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.9.2. Product Portfolio
14.2.9.3. Financial Overview
14.2.9.4. Strategic Overview
14.2.9.5. SWOT Analysis
14.2.10. Other prominent players
14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.10.2. Product Portfolio
14.2.10.3. Financial Overview
14.2.10.4. Strategic Overview
14.2.10.5. SWOT Analysis